Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GE.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used